GSK3B and Alzheimer disease: Glycogen synthase kinase‐3β (GSK‐3β) has broad physiological and pathological functions, such as regulating glucose metabolism, regulating neurodevelopment as an important component of Wnt/wingless signalling 8, 9 and phosphorylating tau at multiple AD‐associated sites 10, 11.